Literature DB >> 21819692

Spontaneous nonthymic tumors in SCID mice.

Peigen Huang1, Susan V Westmoreland, Rakesh K Jain, Dai Fukumura.   

Abstract

SCID mice provide an excellent platform for cancer research. Because of their lack of immunity, SCID mice readily succumb to infectious pathogens and therefore must be maintained in an SPF, barrier-protected environment. Although SPF and barrier facilities prevent infection, SCID mice remain prone to premature death due in part to a high prevalence of spontaneous thymic lymphomas. However, little is known about spontaneous nonthymic tumors in SCID mice. We therefore analyzed the incidence of nonthymic tumor in our defined-flora C.B-17/Icr-SCID/Sed mice and examined their histopathologic characteristics. We necropsied 1060 retired SCID breeders (506 males, 554 females; average ages of 325 and 320 d, respectively) and found that 24 mice had developed nonthymic tumors, yielding an incidence of 2.26% (1.78% in males; 2.71% in females). The incidence of nonthymic tumors was substantially lower than that of thymic lymphomas in our retired SCID breeders (12.3% in males; 4.15% in females). Based on histopathology, 9 nonthymic tumors in male SCID mice consisted of 4 salivary gland myoepiteliomas, 2 rhabdomyosarcomas, and 3 cases of leukemia involving multiple organs. Female SCID mice had 15 nonthymic tumors consisting of 8 mammary adenocarcinomas, 4 salivary gland myoepitheliomas, and 1 case each of leukemia, rhabdomyosarcoma, and fibrosarcoma. In addition, we tested in vivo transplantability and characterized the growth behavior of several of these tumors. To our knowledge, this report is the first comprehensive description of spontaneous nonthymic tumors, including 8 myoepitheliomas and 3 rhabdomyosarcomas, from the same SCID mouse colony. Copyright 2011 by the American Association for Laboratory Animal Science

Entities:  

Mesh:

Year:  2011        PMID: 21819692      PMCID: PMC3123755     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  31 in total

1.  Comparative studies between nude and scid mice on the growth and metastatic behavior of xenografted human tumors.

Authors:  X Xie; N Brünner; G Jensen; J Albrectsen; B Gotthardsen; J Rygaard
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

2.  Spontaneous metastasis, proliferation characteristics and radiation sensitivity of fractionated irradiation recurrent and unirradiated human xenografts.

Authors:  P Huang; A Taghian; D W Hsu; L A Perez; A Allam; M Duffy; A DaCosta; H D Suit
Journal:  Radiother Oncol       Date:  1996-10       Impact factor: 6.280

3.  Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma.

Authors:  S Ristevski; D F Purcell; J Marshall; D Campagna; S Nouri; S P Fenton; D A McPhee; G Kannourakis
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Myoepitheliomas in inbred laboratory mice.

Authors:  J P Sundberg; C A Hanson; D R Roop; K S Brown; H G Bedigian
Journal:  Vet Pathol       Date:  1991-07       Impact factor: 2.221

5.  Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in SCID mice.

Authors:  P Huang; A Allam; A Taghian; J Freeman; M Duffy; H D Suit
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

6.  ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction.

Authors:  Abdo J Najy; Kathleen C Day; Mark L Day
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

7.  Influence of tumor cell and stroma sensitivity on tumor response to radiation.

Authors:  Kazuhiko Ogawa; Yves Boucher; Satoshi Kashiwagi; Dai Fukumura; David Chen; Leo E Gerweck
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

8.  Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.

Authors:  R P Custer; G C Bosma; M J Bosma
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

9.  Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice.

Authors:  Hirokazu Ogino; Seiji Yano; Soji Kakiuchi; Hiroaki Muguruma; Kenji Ikuta; Masaki Hanibuchi; Hisanori Uehara; Kunihiro Tsuchida; Hiromu Sugino; Saburo Sone
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

10.  Skeletal muscle rhabdomyosarcomas in inbred laboratory mice.

Authors:  J P Sundberg; D L Adkison; H G Bedigian
Journal:  Vet Pathol       Date:  1991-05       Impact factor: 2.221

View more
  14 in total

1.  Barriers to generating PDX models of HPV-related head and neck cancer.

Authors:  Nicole D Facompre; Varun Sahu; Kathleen T Montone; Kayla M Harmeyer; Hiroshi Nakagawa; Anil K Rustgi; Gregory S Weinstein; Phyllis A Gimotty; Devraj Basu
Journal:  Laryngoscope       Date:  2017-05-31       Impact factor: 3.325

2.  Ewing Sarcoma PDX Models.

Authors:  Didier Surdez; Lorena Landuzzi; Katia Scotlandi; Maria Cristina Manara
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits.

Authors:  Timothy K Cooper; David K Meyerholz; Amanda P Beck; Martha A Delaney; Alessandra Piersigilli; Teresa L Southard; Cory F Brayton
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

Review 4.  The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints.

Authors:  Santosha Vardhana; Anas Younes
Journal:  Haematologica       Date:  2016-07       Impact factor: 9.941

5.  hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling.

Authors:  Xingya Wang; Kali Chrysovergis; Justin Kosak; Grace Kissling; Mike Streicker; Glenda Moser; Ruifang Li; Thomas E Eling
Journal:  Aging (Albany NY)       Date:  2014-08       Impact factor: 5.682

6.  Spontaneous development of neoplasms in severe combined immunodeficient mice.

Authors:  Rekha Samuel
Journal:  SAGE Open Med Case Rep       Date:  2015-01-19

7.  Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002.

Authors:  Eric K Ring; Rong Li; Blake P Moore; Li Nan; Virginia M Kelly; Xiaosi Han; Elizabeth A Beierle; James M Markert; Jianmei W Leavenworth; G Yancey Gillespie; Gregory K Friedman
Journal:  Mol Ther Oncolytics       Date:  2017-09-13       Impact factor: 7.200

8.  Ectopic TLX1 expression accelerates malignancies in mice deficient in DNA-PK.

Authors:  Konstantin Krutikov; Yanzhen Zheng; Alden Chesney; Xiaoyong Huang; Andrea K Vaags; Valentina Evdokimova; Margaret R Hough; Edwin Chen
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

9.  Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis.

Authors:  Valentina E Schneeberger; Viola Allaj; Eric E Gardner; J T Poirier; Charles M Rudin
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

10.  Incidence of spontaneous lymphomas in non-experimental NOD/Shi-scid, IL-2Rγnull (NOG) mice.

Authors:  Masahiko Yasuda; Tomoyuki Ogura; Takayuki Goto; Mika Yagoto; Yoko Kamai; Chie Shimomura; Nobuhito Hayashimoto; Yukito Kiyokawa; Hideki Shinohara; Riichi Takahashi; Kenji Kawai
Journal:  Exp Anim       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.